Greenwich LifeSciences, Inc. (GLSI:NASDAQ) closed at $14.55 on October 16, 2026, down 5.03% on the day. The stock trades 57.3% below its 52-week high of $34.10 and 87.0% above its 52-week low of $7.78. Over the past year, it gained 53.3%. Greenwich LifeSciences, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -18.12% | -20.88% | +3.41% | -40.66% | +53.32% |
In 252 trading sessions since October 16, 2025, GLSI closed higher on 127 days (50%). Its best day was January 7, 2026 (+21.68%) and its worst was August 28, 2026 (-16.34%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 4 times.
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Find more stocks like GLSI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.